Adicet Bio, Inc. Investment Income, Nonoperating
Adicet Bio, Inc. (ACET) reported Investment Income, Nonoperating of $2.82 million for the 12-month period ending 2019-12-31, per its 10-K filed 2020-03-12.
Discontinued › Income Statement › Other Income
us-gaap:InvestmentIncomeNonoperating · last filed 2020-03-12
- Adicet Bio, Inc. investment income, nonoperating for fiscal 2019 was $2.82M, a 32.63% increase from fiscal 2018.
- Adicet Bio, Inc. investment income, nonoperating for fiscal 2018 was $2.12M.
| Period end | Investment Income, Nonoperating 12 month |
|---|---|
| 2019-12-31 | $2.82M 10-K · filed 2020-03-12 |
| 2018-12-31 | $2.12M 10-K · filed 2020-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |